HighTower Advisors »

Briacell Therapeutics Corp shares owned by HighTower Advisors

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $16k 15k 1.09
2024-03-31 $41k 15k 2.84
2023-12-31 $93k 16k 5.85
2023-09-30 $99k 16k 6.23

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Briacell Therapeutics Corp

Redmond Asset Management
Susquehanna International
Vontobel Holding
Onyx Bridge Wealth Group
Summit Trail Advisors
Bank of America Corporation
Cambridge Investment Research Advisors
Citadel Advisors
Renaissance Technologies
HighTower Advisors
Concord Wealth Partners
XTX Topco
LPL Financial
Group One Trading
National Bank Of Canada /fi/

View all funds holding Briacell Therapeutics Corp